BioSpace News Archive

Cleave Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on VCP/p97 as a novel target in oncology, announced that it has entered into a preclinical research collaboration with Jazz Pharmaceuticals, a global biopharmaceutical company developing life-changing medicines for people with serious diseases. Under the terms of the a

Cerus Corporation (Nasdaq:CERS) announced today that William ‘Obi’ Greenman, Cerus’ president and chief executive officer, and Kevin D. Green, Cerus’ chief financial officer, are scheduled to participate in the following two conferences: The Cantor Fitzgerald Virtual Global Healthcare Conference on Tuesday, September 15 th at 2:00 P.M. ET. The H.C. Wainwright 22 nd Annual Global Investment Conference on

In August 2020, Fotona, based in Europe and the U.S., completed the purchase of the Fox III and Fox IV lasers systems and the EmunDo® Therapy system from A.R.C. Laser GmbH.

OrthoPediatrics Corp., a company focused exclusively on advancing the field of pediatric orthopedics, announced its continued support for the Scoliosis Research Society, including the Company’s Gold Level sponsorship for the 55th Annual Meeting & Course taking place virtually on September 9-13.

American BriVision (Holding) Corporation (OTCQB: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today issued a full clinical study report (CSR) of Vitargus® First-in-Human Phase I Clinical Trial . The safety and preliminary efficacy findings from this study, combined with the unique properties of Vitargus® (BFC-1401), are supportive of further

Reneo Pharmaceuticals announced today that the European Medicines Agency’s (EMA) Committee for Orphan Medicinal Products has granted the company orphan drug designation for REN001, an investigational medicine in development for the treatment of LCHAD deficiency, a fatty acid oxidation disorder (FAOD), and MELAS syndrome, a primary mitochondrial myopathy (PMM).

The clinical trial results demonstrate clearly that PrimeC, NeuroSense’s combination drug, has significant therapeutic potential for amyotrophic lateral sclerosis (ALS) patients. [09-September-2020] HERZLIYA, Israel , Sept. 9, 2020 /PRNewswire/ -- NeuroSense Therapeutics , a Biotech company developing PrimeC, a combination drug which aims to slow ALS progression, ann

Medly Pharmacy, a full-service, digital pharmacy that offers free same-day prescription delivery, has expanded its executive team by welcoming two new members to the company’s C-suite. Robert “Rob” Horowitz will join the company as Chief Financial Officer (CFO) and Prasad Pola will join as Chief Technology Officer (CTO).

Clarity Pharmaceuticals, a clinical-stage radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Rare Paediatric Disease Designation (RPDD) to 64 Cu-SARTATE™, a diagnostic for the clinical management of neuroblastoma. Dr Alan Taylor

Aegis Life, Inc., the leading developer of the next generation of DNA vaccines and therapies for the world’s most dangerous diseases, announced today that it has appointed its co-founder, Hong Jiang, Ph.D., as its Chief Operating Officer (COO).